Repurposing paclitaxel for the treatment of fibrosis: indication discovery for existing drugs.

about

Repurposing paclitaxel for the treatment of fibrosis: indication discovery for existing drugs.

Item

http://www.wikidata.org/entity/Q43207699

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Repurposing paclitaxel for the ...... discovery for existing drugs.

@en

Repurposing paclitaxel for the ...... discovery for existing drugs.

@nl

type

Item

label

Repurposing paclitaxel for the ...... discovery for existing drugs.

@en

Repurposing paclitaxel for the ...... discovery for existing drugs.

@nl

prefLabel

Repurposing paclitaxel for the ...... discovery for existing drugs.

@en

Repurposing paclitaxel for the ...... discovery for existing drugs.

@nl

P1476

Repurposing paclitaxel for the ...... discovery for existing drugs.

@en

P2093

Shu-Feng Zhou

http://www.w3.org/2001/XMLSchema#string

Wei Duan

http://www.w3.org/2001/XMLSchema#string

Xiao-Wu Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Prediction of drug-target interactions for drug repositioning only based on genomic expression similarity

Use of genome-wide association studies for cancer research and drug repositioning

Drug repositioning for diabetes based on 'omics' data mining

Computational drug repositioning: from data to therapeutics.

Identification of novel therapeutics for complex diseases from genome-wide association data.

Systematic drug safety evaluation based on public genomic expression (Connectivity Map) data: myocardial and infectious adverse reactions as application cases.

DiseaseConnect: a comprehensive web server for mechanism-based disease-disease connections.

Computational repositioning and preclinical validation of pentamidine for renal cell cancer.

Discovery and preclinical validation of drug indications using compendia of public gene expression data.

Investigating drug repositioning opportunities in FDA drug labels through topic modeling

P304

4869-4871

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.2147/DDDT.S87771

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26379422

http://www.w3.org/2001/XMLSchema#string

P932

4567211

http://www.w3.org/2001/XMLSchema#string